-
Real-World Healthcare Resource Utilization in Individuals With Phenylketonuria: A Retrospective Observational Study in the United States
Sep 9, 2025, 16:22 PM -
The Incidence and Economic Impact of Major Adverse Events Associated With Intravascular Temperature Management: A Systematic Review, Analysis, and Model
Sep 9, 2025, 16:22 PM -
Advancing Cost-Effectiveness Modeling With R: A Flexible Approach for HTA Submissions
Sep 9, 2025, 16:22 PM -
Health Economic Analysis of Risk- and Age-Based Pneumococcal Vaccination With PCV21 vs. PCV20 in France
Sep 9, 2025, 16:22 PM -
Multi-Level Factors Influencing Active Surveillance Initiation Among Elderly Medicare Beneficiaries Newly Diagnosed With Low-Risk and Favorable Intermediate-Risk Prostate Cancer: An Active Comparator New User Retrospective Cohort Study in the United...
Sep 9, 2025, 16:22 PM -
Understanding the Needs and Aspirations of Emerging HEOR Talent: Results From the ISPOR New Professional and Student Survey
Sep 9, 2025, 16:22 PM -
Funding the Fight Against Antimicrobial Resistance: Learnings From the UK and Sweden’s Pilot Incentive Programs
Sep 9, 2025, 16:22 PM -
Estimating the Clinical and Economic Value of Aztreonam-Avibactam for the Treatment of Metallo-Beta-Lactamase–Producing Carbapenem- Resistant Enterobacterales Infections in China: Adopting the STEDI Value Framework
Sep 9, 2025, 16:22 PM -
Unintended Consequences of MFN Pricing: Global Access Risks and Revenue Impact
Sep 9, 2025, 16:22 PM -
Definitive Staging and Perioperative Treatment for Resectable Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC): A UK Perspective
Sep 9, 2025, 16:22 PM -
Patient Preference Studies in HTA for Rare Diseases: A Cross-Country Analysis of EU-4, UK, and Canada
Sep 9, 2025, 16:22 PM -
Delayed Access to Diabetes Technology in Children With Migration Background: A Cross-Sectional Study on Treatment Equity in Austria
Sep 9, 2025, 16:22 PM -
Personalized Treatment Optimization Using Reinforcement Learning on Real-World Data (RWD)
Sep 9, 2025, 16:22 PM -
Effect of the Inflation Reduction Act on Drug Innovation
Sep 9, 2025, 16:22 PM -
Impact of Delayed or Missing Diagnosis of Chronic Kidney Disease
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Perioperative Pembrolizumab for Early Stage Non-Small Cell Lung Cancer (NSCLC) in Greece
Sep 9, 2025, 16:22 PM -
Societal and Economic Burden of Obesity in Bulgaria
Sep 9, 2025, 16:22 PM -
Comprehensive Uncertainty Assessment in Economic Evaluations of AI-Based Health Technologies: Pitfalls and Recommendations
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Systemic Therapies in Adults with KRAS(G12C) Metastatic Colorectal Cancer in Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Prediabetes Prevalence and Progression in the UAE: Insights for Early Intervention and Resource Optimization
Sep 9, 2025, 16:22 PM
